The risk of bleeding with warfarin: A systematic review and performance analysis of clinical prediction rules

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Thrombosis and Haemostasis

• Publication date

  2007-10-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1160/TH07-04-0297PMID 18000602
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Warfarin prescribing in atrial fibrillation: the impact of physician, patient, and hospital characteristics.

  2006cited by this paper
• Development of a contemporary bleeding risk model for elderly warfarin recipients.

  2006cited by this paper
• Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF).

  2006influential reference
• Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation.

  2005cited by this paper
• Bleeding Risk Index in an anticoagulation clinic. Assessment by indication and implications for care.

  2005influential reference
• Drug interactions and risk of acute bleeding leading to hospitalisation or death in patients with chronic atrial fibrillation treated with warfarin

  2005cited by this paper
• The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

  2004cited by this paper
• Diagnostic tests 4: likelihood ratios

  2004cited by this paper
• Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

  2004cited by this paper
• The outpatient bleeding risk index: validation of a tool for predicting bleeding rates in patients treated for deep venous thrombosis and pulmonary embolism.

  2003influential reference
• Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism.

  2003cited by this paper
• Searching for clinical prediction rules in MEDLINE.

  2001cited by this paper
• Users ’ Guides to the Medical Literature

  2000influential reference
• Users' guides to the medical literature: XXII: how to use articles about clinical decision rules. Evidence-Based Medicine Working Group.

  2000cited by this paper
• Why do patients with atrial fibrillation not receive warfarin?

  2000cited by this paper
• Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism.

  1999influential reference
• Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin.

  1998influential reference
• Clinical prediction rules. A review and suggested modifications of methodological standards.

  1997influential reference
• Assessment of a Bleeding Risk Index in Two Cohorts of Patients Treated with Oral Anticoagulants

  1996cited by this paper
• Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly.

  1995cited by this paper
• Users' guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence-Based Medicine Working Group.

  1994cited by this paper
• Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group.

  1994cited by this paper
• Users' Guides to the Medical Literature: III. How to Use an Article About a Diagnostic Test: B. What Are the Results and Will They Help Me In Caring for My Patients?

  1994cited by this paper
• Users' Guides to the Medical Literature: III. How to Use an Article About a Diagnostic Test A. Are the Results of the Study Valid?

  1994cited by this paper
• Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention.

  1993cited by this paper
• Integrating Stratum-specific Likelihood Ratios with the Analysis of ROC Curves

  1993cited by this paper
• A bleeding risk index for estimating the probability of major bleeding in hospitalized patients starting anticoagulant therapy.

  1990cited by this paper
• Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy.

  1989influential reference
• Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy.

  1987cited by this paper
• Users ' Guides to the Medical Literature : III . How to Use an Article About a Diagnostic Test : A . Are the Results of the Study Valid ?

  year unknowncited by this paper

• The Value of Using Bedside Point of Care Testing for International Normalized Ratio in Patients on Warfarin Undergoing Dental Procedures and Bleeding Assessment; A Single Center Prospective Study

  2025influential citation
• Icaritin Sensitizes Thrombin- and TxA 2 -Induced Platelet Activation and Promotes Hemostasis via Enhancing PLCγ2-PKC Signaling Pathways

  2023cites this paper
• Machine learning to predict major bleeding during anticoagulation for venous thromboembolism: possibilities and limitations

  2023cites this paper
• The high-risk bleeding category of different scores in patients with venous thromboembolism: Systematic review and meta-analysis.

  2021cites this paper
• Enzyme-linked immunosorbent assays for therapeutic drug monitoring coumarin oral anticoagulants in plasma.

  2018cites this paper
• Anaemia as an independent key risk factor for major haemorrhage in patients treated with vitamin K antagonists: Results of the SCORE prospective cohort.

  2017cites this paper
• Bleeding risk in patients with unprovoked venous thromboembolism: A critical appraisal of clinical prediction scores.

  2017cites this paper
• Non-vitamin K antagonist oral anticoagulants for the prevention of recurrent venous thromboembolism.

  2016cites this paper
• The Problem of Atrial Fibrillation in Patients with Chronic Kidney Disease.

  2016cites this paper
• [Warfarin-associated epidural hematoma with spinal cord compression].

  2016cites this paper
• Diagnosis and Treatment of Lower Extremity Deep Vein Thrombosis: Korean Practice Guidelines

  2016cites this paper
• Predictors of hospital mortality and serious complications in patients admitted with excessive warfarin anticoagulation.

  2016cites this paper
• Implementation of a Computerized Decision Support System for Warfarin Dosing in Hemodialysis Patients: A Study of Effectiveness and Safety

  2015cites this paper
• Minimizing the risk of hemorrhagic stroke during anticoagulant therapy for atrial fibrillation

  2015cites this paper
• Self-Inflicted Intraoral Hematoma in a Cardiac Patient Receiving Oral Anticoagulant Therapy-A Case Report

  2015cites this paper
• DURING THE COURSE OF ORAL ANTICOAGULATION WARRANTS IMMEDIATE INR CHECK

  2015cites this paper
• Sharp tooth induced sublingual hematoma in a patient with elevated international normalized ratio

  2015cites this paper
• [Comparison of the HAS-BLED and ATRIA scores for the risk of bleeding in patients aged 75 and over receiving vitamin K antagonist (VKA) therapy and educated VKA-management].

  2015cites this paper
• Anticoagulación estratificada por riesgos

  2014cites this paper
• Trauma and Sharp tooth induced labial vestibule hematoma in a patient with elevated International normalized ratio.

  2014cites this paper
• The ten commandments of laboratory testing for emergency physicians

  2014cites this paper
• Cardiovascular Issues and Renal Disease

  2014cites this paper
• Hémorragie grave et scores prédictifs : étude longitudinale sur un an de patients ambulatoires, éduqués, sous AVK

  2014cites this paper
• Clinical performance of bleeding risk scores for predicting major and clinically relevant non‐major bleeding events in patients receiving warfarin

  2013cites this paper
• Epidemiology of Chronic Kidney Disease

  2013cites this paper
• [Hemorrhagic syndrome after the treatment with peroral anticoagulants - antagonists of vitamin K].

  2013cites this paper
• Preventing stroke in patients with chronic kidney disease and atrial fibrillation: benefit and risks of old and new oral anticoagulants.

  2013cites this paper
• Validation of a score for predicting fatal bleeding in patients receiving anticoagulation for venous thromboembolism.

  2013cites this paper
• Évaluation du risque hémorragique des personnes âgées de plus de 75 ans sous anti-vitamine K, ayant reçu une éducation thérapeutique

  2013cites this paper
• Hematoma formation during breast core needle biopsy in women taking antithrombotic therapy.

  2013cites this paper
• Bleeding risks associated with vitamin K antagonists.

  2013cites this paper
• Tossing a coin or using common sense

  2013cites this paper
• Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

  2013cites this paper
• Optimal Duration of Anticoagulant Therapy

  2013cites this paper
• [Epidemiology of chronic kidney disease].

  2012cites this paper
• Chronic Kidney Disease and Atrial Fibrillation: A Contemporary Overview.

  2012cites this paper
• Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

  2012cites this paper
• Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

  2012cites this paper
• Risk factors of vitamin K antagonist overcoagulation.

  2012cites this paper
• Introduction to the ninth edition: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

  2012cites this paper
• Clinical prediction rules in the physiotherapy management of low back pain: a systematic review.

  2012cites this paper
• The role of community pharmacy in post-discharge warfarin management

  2012cites this paper
• Enquête sur la qualité du suivi ambulatoire des anticoagulantsoraux chez les patients de plus de 75 ans

  2012cites this paper
• Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.

  2012cites this paper
• Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

  2012cites this paper
• ANTITHROMBOTIC THERAPY AND PREVENTION OF THROMBOSIS, 9TH ED: ACCP GUIDELINES

  2012cites this paper
• Evidence-Based Clinical Practice Guidelines ed: American College of Chest Physicians Therapy and Prevention of Thrombosis, 9th Oral Anticoagulant Therapy : Antithrombotic

  2012cites this paper
• Risk of bleeding with oral anticoagulants: an updated systematic review and performance analysis of clinical prediction rules

  2011influential citation
• [Atrial fibrillation and chronic kidney disease].

  2011cites this paper
• Migotanie przedsionków a przewlekła choroba nerek Atrial fibrillation and chronic kidney disease

  2011cites this paper
• Ischaemic stroke and bleeding rates in ‘real-world’ atrial fibrillation patients

  2011cites this paper
• Chapitre 1 – Pathologie Veineuse Aiguë: Anatomie des Veines Profondes

  2011cites this paper
• Rethinking testing for pulmonary embolism: less is more.

  2011cites this paper
• Major bleeding risk associated with warfarin and co‐medications in the elderly population

  2011cites this paper
• Characterization of the proportion of untreated and antiplatelet therapy treated patients with atrial fibrillation.

  2011cites this paper
• Antimetastatic, antineoplastic, and toxic effects of 4-hydroxycoumarin in a preclinical mouse melanoma model

  2010cites this paper
• Predictors of anticoagulation in hospice patients with lung cancer

  2010cites this paper
• Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'.

  2009cites this paper
• Early and comprehensive management of atrial fibrillation: proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'.

  2009cites this paper
• Anticoagulation: where we are and where we need to go

  2009cites this paper
• Glycoprotein inhibitors in patients on chronic anticoagulation: Safe enough or too much risk?

  2009cites this paper
• Coumarin use in dialysis patients with atrial [corrected] fibrillation: yes, after individual risk stratification.

  2009cites this paper
• [Preventive anticoagulation: example of risk/benefit analysis].

  2009cites this paper
• Balancing thromboembolism and bleeding risks: insights from anticoagulation for prosthetic heart valves.

  2009cites this paper
• Dilemmas in the management of atrial fibrillation in chronic kidney disease.

  2009cites this paper
• Bleeding with anticoagulation therapy – Who is at risk, and how best to identify such patients

  2009cites this paper
• Clinical prediction rules: new opportunities for pharma.

  2009cites this paper
• Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/ Stenting

  2009cites this paper
• Percutaneous closure of the left atrial appendage in atrial fibrillation: an alternative if standard treatment fails?

  2009cites this paper
• Anticoagulation variability: is it the physician, patient or hospital?

  2009cites this paper
• Anticoagulacin preventiva: ejemplo de anlisis de riesgo/beneficio

  2009cites this paper
• Effect of oral antiplatelet agents on major bleeding in users of coumarins

  2008cites this paper
• [Genetic predisposition to bleeding during oral anticoagulants treatment].

  2008cites this paper
• Self-management of oral anticoagulation reduces major outcomes in the elderly

  2008cites this paper
• Venous Thromboembolism Prophylaxis in Foot and Ankle Surgery: A Literature Review

  2008influential citation
• Genetic predisposition to bleeding during treatment oral anticoagulants treatment

  2008cites this paper
• Pro: ‘Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions’

  2008cites this paper
• Challenges facing anticoagulation among the elderly and frail.

  2008cites this paper
• Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'

  2008cites this paper
• Risk factors of vitamin K antagonist overcoagulation

  2008cites this paper
• Bleeding complications in patients on anticoagulants who would have been disqualified for clinical trials

  2008cites this paper
• Current awareness: Pharmacoepidemiology and drug safety

  1996cites this paper